Other specified type of carcinoma in situ of breast
ICD-10 D05.8 is a billable code used to indicate a diagnosis of other specified type of carcinoma in situ of breast.
Carcinoma in situ (CIS) of the breast refers to a group of abnormal cells that are found in the lining of the breast ducts or lobules. These cells have the potential to become invasive cancer but are not yet classified as malignant. The term 'other specified type' indicates that the carcinoma in situ does not fit into the more common categories such as ductal carcinoma in situ (DCIS) or lobular carcinoma in situ (LCIS). Surveillance protocols for patients diagnosed with D05.8 typically involve regular mammograms and clinical breast exams, as well as potential MRI imaging, depending on individual risk factors. The risk of progression to invasive breast cancer varies based on the specific type of carcinoma in situ, with some types having a higher likelihood of progression than others. Patients with carcinoma in situ are often monitored closely, and treatment options may include surgical excision, radiation therapy, or hormonal therapy, depending on the characteristics of the tumor and patient preferences.
Detailed pathology reports, treatment plans, and follow-up care notes.
Diagnosis of carcinoma in situ, treatment planning, and monitoring for progression.
Accurate coding requires understanding of the specific type of carcinoma and its treatment implications.
Imaging reports, findings from mammograms or MRIs, and recommendations for follow-up imaging.
Imaging for surveillance of patients with a history of carcinoma in situ.
Radiologists must ensure that imaging findings are clearly linked to the diagnosis of carcinoma in situ.
Used when a patient with D05.8 undergoes surgical intervention.
Surgical notes detailing the procedure and findings.
Oncologists must ensure that the diagnosis is clearly linked to the surgical procedure.
Coding D05.8 is crucial for accurately representing the patient's diagnosis of carcinoma in situ that does not fit into the more common categories. It ensures appropriate surveillance and treatment protocols are followed.
